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Abstract 
Pulmonary surfactant protein A (SP-A) augments the uptake of phospholipid liposomes containing dipalmitoylphosphatidylcholine 
(DPPC) by alveolar type II cells. The SP-A-mediated uptake process of lipids by type II cells have not been well understood. In the 
present study we investigated the SP-A-mediated interaction of phospholipids with plasma membrane isolated from alveolar type II cells. 
SP-A increased the amount of liposomes containing radiolabeled DPPC associated with type II cell plasma membrane by 4-fold compared 
to the control without SP-A when analyzed by sucrose density gradient centrifugation. This effect is dependent upon the SP-A 
concentration. The enhancement was inhibited by anti-SP-A antibody and EGTA. When type II cell plasma membrane and liposomes 
containing [14C]DPPC and [3H]triolein were coincubated with or without SP-A, analysis on sucrose density gradients revealed that the 
profiles of [14C]DPPC and [3H]triolein in each fraction were almost identical with or without SP-A, indicating that SP-A mediates the 
binding of liposomes to plasma membrane but not transfer of DPPC. SP-A increased the association of liposomes containing DPPC with 
the membrane by 2-fold more than that containing 1-palmitoyl-2-1inoleoyl-phosphatidylcholine (PLPC). SP-A induced aggregation of 
phospholipid liposomes containing PLPC as well as those containing DPPC, but the final turbidity of DPPC liposomes aggregated by 
SP-A was only by 15% greater than that of PLPC liposomes. The amount of DPPC liposomes associated with the plasma membrane 
derived from type II cells was 2-fold greater than that from liver. We speculate that the SP-A-mediated interaction of lipids with type II 
cell plasma membrane may contribute, in part, to the lipid uptake process by type II cells. 
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1. Introduction 
Alveolar type II cells produce and secrete pulmonary 
surfactant hat plays important roles in preventing the 
alveoli from collapsing and in host defence mechanism of 
the lung. The major surfactant-associated protein SP-A 
with reduced and denatured molecular masses of 26-38 
kDa contributes to the regulation of phospholipid home- 
ostasis in the alveolar space. This protein interacts with 
phospholipids. It binds to phosphatidylcholine, especially 
strongly to dipalmitoylphosphatidylcholine (DPPC) [1], an 
essential lipid component of the surfactant. It causes aggre- 
Abbreviations: SP-A, pulmonary surfactant protein A; DPPC, dipal- 
mitoylphosphatidylcholine; PLPC, l-palmitoyl-2-1inoleoyl-phosphatidyl- 
choline. 
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gation of the phospholipid vesicles containing DPPC in a 
Ca2÷-dependent manner [2]. SP-A also interacts with alve- 
olar type II cells. It inhibits secretion of phosphatidyl- 
choline by type II cells [3,4] via a putative receptor 
expressed on alveolar type II cells [5,6]. 
Several evidences that surfactant lipids are taken up and 
recycled by type II cells have been accumulated [7-12]. 
Claypool et al. [13] reported that hydrophobic surfactant 
proteins enhanced the uptake of surfactant-like lipids by 
primary cultures of type II cells. In vivo study by Wright 
et al. [14] showed that the surfactant subfraction that 
contained SP-A was taken up into rabbit lungs to a greater 
extent than that without SP-A. They demonstrated that 
SP-A augments the uptake of phospholipids by freshly 
isolated type II cells [15]. The SP-A-mediated uptake of 
phosphatidylcholine by type II cells is preferential for 
DPPC [16]. Although these experimental pproaches have 
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provided the hypothesis that SP-A may direct lipids to type 
II cells in the alveolar space, the uptake process of lipids 
by type II cells have not been well understood. We investi- 
gated the SP-A-mediated interaction of phospholipids with 
plasma membrane isolated from alveolar type II cells, 
since this may be an important first step to initiate uptake 
process of lipids into these cells. 
2. Materials and methods 
2.1. Lipids 
1,2-Dipalmitoyl-L-3-phosphatidylcholine (DPPC), 1- 
palmitoyl-2-1inoleoyl-t-3-phosphatidylcholine (PLPC), egg 
phosphatidylcholine (PC), phosphatidylglycerol (PG) and 
cholesterol were purchased from Sigma. 1-Palmitoyl-2- 
[14C]palmitoyl-L-3-phosphatidylcholine ([14 C]DPPC), di- 
palmitoylphosphatidyl[ N-methyl-3H]choline ([3H]DPPC) 
and [9,10(n)-3H]triolein ([ 3H]triolein) were obtained from 
New England Nuclear Research. 1-Palmitoyl-2- 
[14C]linoleoyl-L-3-phosphatidylcholine ([~4C]PLPC) was 
purchased from Amersham. 
2.2. Liposome preparation 
A phospholipid mixture (60% of DPPC or PLPC, 20% 
egg PC, 15% PG and 5% cholesterol, by weight) in 
chloroform/methanol (2:1, v /v)  was dried under nitrogen 
and hydrated in 5 mM Tris buffer (pH 7.4) containing 0.15 
M NaCI (1.0 mg phospholipid/ml). This mixture was then 
probe-sonicated with a Sonifier cell disruptor (Heat Sys- 
tem-Ultrasonics). The liposomes was radiolabeled with a 
trace amount of [3H]DPPC, [14C]DPPC, [14C]PLPC or 
[3H]triolein. 
2.3. Purification of SP-A 
Surfactant was isolated from Sprague-Dawley rats given 
intratracheal instillation of 10 mg of silica in saline 4 
weeks before lung lavage [17]. The surfactant was purified 
by the method of Hawgood et al. [2], and then delipidated 
by extraction with 1-butanol (98 ml of butanol per 2 ml 
pellet). The lipids were separated from the protein precipi- 
tate by centrifugation and SP-A was purified from the 
protein precipitate as described previously [5]. Briefly, the 
protein was suspended in 5 mM Tris buffer (pH 7.4) and 
dialyzed against he same buffer. The protein suspension 
was centrifuged at 150000 X gay for 1 h and the super- 
natant was applied to affinity chromatography on man- 
nose-Sepharose 6-B [18] followed by gel filtration over 
Bio-Gel A-5m (Bio-Rad). SP-D was also purified from rat 
lung lavage fluids as described previously [19], based on 
the method reported Persson et al. [20]. The protein con- 
tent was estimated by the method of Lowry et al. [21] 
using bovine serum albumin as the standard. 
2.4. Isolation of plasma membrane from alveolar type H 
cells 
Alveolar type II cells were isolated from adult male 
Sprague-Dawley rats by tissue dissociation with elastase 
(Elastin Product) and metrizamide density gradients by the 
method of Dobbs and Mason [22]. Freshly isolated type II 
cells (approx. 100.106 cells) were suspended in 1.5 to 2.0 
ml of 5 mM Tris buffer (pH 7.4) and left on ice for 10 
min. The resulting cell suspension was homogenized with 
a Dounce homogenizer. The homogenate was quickly ad- 
justed to 0.9 M sucrose using 2 M sucrose and layered 
appropriately on a gradient consisting of 1 ml each of 0.2, 
0.3, 0.4, 0.5, 0.6, 0.7, 0.8 M sucrose and 3 ml each of 0.9 
M and 1.5 M sucrose. This gradient system is a modifica- 
tion of that described by Duck-Chong [23]. The gradients 
were centrifuged at 90000 X gav for 4 h and the bands 
between 0.9 and 1.5 M sucrose were collected as a plasma 
membrane fraction. The plasma membrane isolated from 
100 • 10  6 type II cells contained 367 + 115 nmol (mean + 
S.D., n = 3) of phospholipids and 450 ___ 177 /xg of pro- 
teins. Alkaline phosphatase was measured as a marker of 
plasma membrane by the method of Edelson et al. [24]. 
Alkaline phosphatase has been shown to be localized in 
the plasma membrane of alveolar type II cells [24]. To 
isolate the plasma membrane derived from liver, rat liver 
was minced and homogenized with Potter homogenizer, 
and the plasma membrane fraction was isolated by sucrose 
density gradient centrifugation asdescribed above. 
2.5. Interaction of phospholipid liposomes with plasma 
membrane 
40 /zg protein of plasma membrane, which contained 
33.5 ___ 3.5 nmol (mean ___ S.D., n = 3) of phospholipids, 
was incubated with 1 ml of 10 mM Tris buffer (pH 7.4) 
containing 0.15 M NaCI, 1 mM CaCI 2, phospholipid 
liposome (40 nmol as DPPC or PLPC) with a trace amount 
of [14C]DPPC, [3H]DPPC or [14C]PLPC in the absence or 
the presence of 10 /xg/ml SP-A at 37°C for 60 min. The 
incubation mixture was immediately processed for sucrose 
density gradient centrifugation to separate the liposomes 
that were associated with the plasma membrane from 
unbound liposomes. After the incubation 1 ml of Tris 
buffer (pH 7.4) containing 0.15 M NaC1 and 1 mM CaC12 
was added into the reaction mixture and layered on a top 
of a gradient consisting of 2 ml each of 0.2, 0.4, 0.6 M 
sucrose and 4 ml of 0.8 M sucrose. The gradients were 
centrifuged at 93 000 × gay at 4°C for 4 h. 2 ml each from 
the top was collected, and the radioactivity in each fraction 
was counted. The final 2 ml was collected with the pellet. 
Each fraction was also assayed for alkaline phosphatase 
activity [24]. In some experiments, the plasma membrane 
was incubated with liposome containing [14C]DPPC and a 
trace amount of [3H]triolein, non-exchangeable marker, 
and processed for sucrose density gradient centrifugation. 
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2.6. Liposome aggregation 
Liposome aggregation was performed by the method 
based on that described by Hawgood et al. [2]. SP-A (20 
~g/ml)  in 20 mM Tris buffer (pH 7.4) containing 0.15 M 
NaC1 was preincubated for 3 min with 100 /~g/ml unil- 
amellar liposomes containing DPPC or PLPC prepared as 
described above. After equilibration, turbidity was mea- 
sured at 400 nm using a Hitachi U2000 spectrophotometer 
at room temperature. Following the initial absorbance r ad- 
ings, CaC12 was added to a final concentration f 5 mM at 
a time of 30 s and turbidity was further measured until a 
time of 10 min. 
3. Results 
Phospholipid liposomes containing [3H]DPPC were in- 
cubated with the plasma membrane isolated from type II 
cells in the absence or the presence of SP-A, and processed 
for sucrose density gradient centrifugation. Since SP-A 
induces liposome aggregation [2], control experiment with- 
out plasma membrane was performed (Fig. 1A). More than 
90% of radioactivities were found in the fractions cosedi- 
mented with 0 and 0.2 M sucrose in the absence of SP-A, 
while the profile of radioactivities associated with the 
gradient fractions shifted to the right in the presence of 
SP-A; this is likely to be due to vesicle aggregation 
induced by SP-A. However, the radioactivities associated 
with the pellet remained less than 1% of total radioactivi- 
ties even in the presence of SP-A. When the plasma 
membrane was incubated with liposomes, significant 
amounts of radioactivities were recovered in the pellet 
(Fig. 1B). The percent of radioactivity in the pellet fraction 
in the absence or the presence of SP-A was 2.83 _ 0.7% 
(mean + S.D., n = 3) or 11.97 ___ 2.49%, respectively. In- 
cubation with SP-A significantly (P  < 0.001) increased the 
liposomes recovered in the pellet. Inclusion of 5 mM 
EGTA or 100/xg/ml anti-SP-A polyclonal antibody in the 
incubation mixture reduced the percent of radioactivity 
recovered in the pellet; 4.0% or 3.9% (mean of two 
experiments), respectively, when that of control was 9.5%. 
When boiled SP-A was used instead of native SP-A, only 
1.9% (mean of two experiments) of radiolabeled liposomes 
was recovered in the pellet fraction. When SP-D (10 
/xg/ml) was used instead of SP-A, only 2.45% (mean of 
two experiments) of liposome was associated with type II 
cell plasma membrane. Each fraction obtained was assayed 
for alkaline phosphatase activity (Fig. 1C). Approx. 70% 
of alkaline phosphatase activity was associated with the 
pellet fraction, indicating that most of the plasma mem- 
brane was recovered in the pellet. These data indicate that 
SP-A increases the association of phospholipid liposomes 
with type II cell plasma membrane, and suggest that SP-A 
mediates the transfer or the binding of lipid to plasma 
membrane. 
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Fig. 1. Effect of SP-A on interaction of phospholipid liposomes with 
plasma membrane isolated from type II cells. Phospholipid liposomes (40 
nmol as dipalmitoylphosphatidylcholine, DPPC) containing 60% DPPC, 
20% egg phosphatidylcholine, 15% phosphatidylglycerol and 5% choles- 
terol, and a trace amount of [3H]DPPC were incubated without (panel A) 
or with (panel B) plasma membrane (40/zg protein) isolated from type II 
cells in the absence (12) or the presence ( I )  of 10 ~zg/ml SP-A at 37°(: 
for 60 min. The incubation mixture was then layered on a top of a 
gradient consisting of 2 ml each of 0.2, 0.4, 0.6 M sucrose and 4 ml of 
0.8 M sucrose and centrifuged to separate the liposomes associated with 
plasma membrane from unbound liposomes. After centrifugation, 2 ml 
each from the top was collected and the final 2 ml was collected with the 
pellet. The radioactivity in each fraction was then counted. Each fraction 
obtained in the experiment shown in panel B was assayed for alkaline 
phosphatase activity (Panel C) as described in Section 2. The data shown 
are representative for three experiments. 
To examine whether SP-A mediates the transfer or the 
binding of lipid to plasma membrane, plasma membranes 
isolated from type II cells were incubated with liposomes 
56 Y. Kuroki et a l . /  Biochimica et Biophysica Acta 1281 (1996) 53-59 
A.  SP -A  ( - )  so 
12000 5000 1 
g 
6ooo =o ~o 
2000 " 1000 ~ 0 0 10 20 30 4() 
, • , . . . . . . .  o sP -A  (~ym0)  
0 0.2 0.4 0.6 0.8 ppt 
sucrose (M) Fig. 3. The association of phospholipid liposomes with 
membrane is dependent upon SP-A concentration. The 
(40 /zg protein) isolated from type II ceils was incubat 
50 
B. SP-A (+) 
5OOO 3O00 
g 
o 
(40 nmol as dipalmitoylphosphatidylcholine, DPPC) containing 60% 
o 8 "0.'2 "o.;I o .~  0.'8 " 
sucrose (M) 
Fig. 2. SP-A mediates the binding of phospholipid liposomes but not the 
transfer of lipids to plasma membrane isolated from type II cells. The 
plasma membrane (40 /zg protein) isolated from type 1I cells was 
incubated liposomes (40 nmol as dipalmitoylphosphatidylcholine, DPPC) 
containing 60% DPPC, 20% egg phosphatidylcholine, 15% phosphatidyl- 
glycerol and 5% cholesterol, and a trace amount of [)4C]DPPC (O)  and 
[3H]triolein (0 )  in the absence (panel A) or the presence (panel B) of 10 
/zg/ml SP-A at 37°C for 60 min. The reaction mixture was then 
immediately processed for sucrose density gradient centrifugation and the 
radioactivity in each fraction collected was counted as described in 
Section 2. The data shown are representative for three experiments. 
containing [14C]DPPC and [3H]triolein, non-exchangeable 
marker, in the absence or the presence of SP-A, and 
processed for sucrose density gradient centrifugation. The 
radioactivities of 14C and 3H in the fractions obtained were 
shown in Fig. 2. The profiles of 14C and 3H in the sucrose 
density gradients were almost identical in both the absence 
and the presence of SP-A. The data clearly indicate that 
SP-A mediates the binding of liposomes to plasma mem- 
brane but not the transfer of DPPC. 
We examined the liposome association with type II cell 
plasma membrane in various concentrations of SP-A (Fig. 
3). The percent of radioactivities a sociated with the plasma 
membrane increased in a manner dependent upon SP-A 
concentration. Only two to three percents of radioactivity 
was recovered in the pellet fraction without plasma mem- 
brane in the presence of 20 and 40 /xg/ml SP-A. Next, we 
compared the liposomes containing 1-palmitoyl-2- 
linoleoyl-phosphatidylcholine (PLPC) to those containing 
DPPC, 20% egg phosphatidylcholine, 15% phosphatidylglycerol and 5% 
cholesterol, and a trace amount of [14 C]DPPC with various concentrations 
of SP-A at 37°C for 60 min. The reaction mixture was then immediately 
processed for sucrose density gradient centrifugation and the radioactivity 
in each fraction collected was counted. The data represent percents of 
radiolabeled liposomes associated with the plasma membrane fraction in 
total radioactivities a  described in Section 2. The values are means + S.D., 
n=3.  
DPPC on the association with type II cell plasma mem- 
brane. When DPPC liposomes were incubated with type II 
cell plasma membrane in the presence of 10/xg/ml SP-A, 
6.67% of liposomes was associated with the membrane 
(Table 1). In contrast, only 3.70% of PLPC lipsomes was 
associated with the membrane (P < 0.005 compared to 
DPPC liposomes). When the background (without SP-A) 
was subtracted, SP-A increased the association of DPPC 
Table 1 
The SP-A-mediated association of dipalmitoylphosphatidylcholine 
(DPPC)-containing liposomes with type II cell plasma membrane is 
significantly greater than that of 1-palmityol-2-1inoleoylphospatidylcho- 
line (PLPC)-containing liposomes 
14 Phosphatidylcholine SP-A % of [ C]phosphatidylcholine 
consisiting of associated a 
liposomes 
DPPC - 2.15 + 0.42 
DPPC + 6.67_+ 1.32 bx 
PLPC - 1.51 + 0.57 
PLPC + 3.70 "t- 0.75 d 
a Phospholipid liposomes (40 nmol as DPPC or PLPC) containing 60% 
DPPC or PLPC, 20% egg phosphatidylcholine, 15% phosphatidylglycerol 
and 5% cholesterol, and a trace amount of [14C]DPPC or [14C]PLPC 
were incubated with plasma membrane (40 ixg protein) isolated from 
type II cells in the absence or the presence of 10 /xg/ml SP-A at 37°C 
for 60 min. The incubation mixture was then processed for sucrose 
density gradient centrifugation to separate the liposomes associated with 
plasma membrane from unbound liposomes as described under Section 2. 
The data represent percents of radiolabeled liposomes associated with the 
membrane fraction in total radioactivities. Values are means + S.D., n = 5. 
b p < 0.005 when compared to PLPC, SP-A( + ). 
c p < 0.001 when compared to DPPC, SP-A( - ). 
d p < 0.002 when compared to PLPC, SP-A( - ). 
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Fig. 4. The SP-A-induced aggregation f phosphlipid liposomes consist- 
ing of dipalmitoylphosphatidylcholine (DPPC) and 1-palmitoyl-2- 
linoleoyl-phosphatidylcholine (PLPC). SP-A (20 /xg/ml) in 20 mM Tris 
buffer (pH 7.4) containing 0.15 M NaC1 were preincubated for 3 min 
with 100 /.Lg/ml unilamellar liposomes consisting of 60% DPPC (©) or 
PLPC (O), 20% egg phosphatidylcholine, 15% phosphatidylglycerol and
5% cholesterol. After equilibration, turbidity was measured at400 nm at 
room temperature. Following the initial absorbance r adings, CaC12 was 
added to a final concentration f 5 mM at a time of 30 s and turbidity was 
further measured until a time of 10 min. The values are means+S.D., 
n~4.  
l iposomes with the type II cell plasma membrane by 2-fold 
more than that of PLPC liposomes (4.52% vs. 2.19%). 
Since SP-A causes aggregation of phospholipid vesicles 
[2], we examined whether this difference is simply because 
SP-A induces aggregation of l iposomes containing DPPC 
by a 2-fold greater extent han those containing PLPC. The 
turbidity induced by SP-A was measured using liposomes 
containing DPPC or PLPC. SP-A was able to induce both 
types of phospholipid vesicles; the final turbidity of DPPC 
or PLPC liposomes was 0.156 + 0.02 A400 unit (mean ___ 
Table 2 
The SP-A-mediated association of liposomes with the plasma membrane 
derived from type II cell is significantly greater than that derived from 
liver 
Source of plasma SP-A % of [14 C]phosphatidylcholine 
membrane associated a 
Type II cell - 1.88 + 0.16 
Type II cell + 7.81 +0.48 b,c 
Liver - 0.93 + 0.17 
Liver + 3.73 + 1.01 d 
Phospholipid liposomes (40 nmol as dipalmitoylphosphatidylcholine, 
DPPC) containing 60% DPPC, 20% egg phosphatidylcholine, 15% phos- 
phatidylglycerol and 5% cholesterol, and a trace amount of [14C]DPPC 
were incubated with plasma membrane (40 /xg protein) isolated from 
type II cells or liver in the absence or the presence of 10/.Lg/ml SP-A at 
37°C for 60 rain. The incubation mixture was then processed for sucrose 
density gradient centrifugation to separate he liposomes associated with 
plasma membrane from unbound liposomes as described in Section 2. 
The data represent percents of radiolabeled liposomes associated with the 
membrane fraction in total radioactivities. Values are means + S.D., n = 5. 
b p < 0.005 when compared to liver plasma membrane, SP-A( + ). 
c p < 0.001 when compared to type II cell plasma membrane, SP-A(-). 
d p < 0.002 when compared to liver plasma membrane, SP-A( - ). 
S.D., n = 4) or 0.136 + 0.018 A400 unit, respectively (Fig. 
4). Only 15% difference in the final turbidity was found 
between these species of PC in the SP-A-mediated vesicle 
aggregation. 
Next, we performed the vesicle association experiments 
with the plasma membranes i olated from liver and type II 
cells. 7.8% of the vesicle radioactivity was recovered in 
the membrane fraction isolated from type II cells, while 
only 3.7% was associated with the membrane isolated 
from liver (P  < 0.005) in the presence of SP-A (Table 2). 
This indicates that the plasma membrane from type II cells 
possesses the higher activity on liposome association in- 
duced by SP-A than that from liver. 
4. Discussion 
Several studies have shown that surfactant lipids are 
taken up by alveolar type II cells and cleared from the 
alveoli [7-12]. This process contributes to the recycling 
and reutilization of surfactant phospholipids. The hy- 
drophobic surfactant proteins as well as SP-A enhances the 
uptake of lipids by type II cells [13]. Synthetic SP-B 
peptides and the native protein also augment lipid uptake 
by fibroblasts [25]. In contrast, SP-A failed to enhance 
lipid uptake by fibroblasts [15], indicating that the mecha- 
nism of uptake process by this protein is different from 
that by the hydrophobic protein; the latter appears to be 
due to the nonspecific l iposome fusion. Wright et al. [15] 
described that the metabolic inhibitors decreased the stimu- 
latory effect of SP-A by 30-50% on liposome uptake by 
type II cells. This indicates that the uptake process is in 
part dependent on cellular process. However, the details of 
the uptake process of lipids into type II cells have not been 
well understood. In this study we demonstrated that SP-A 
preferentially enhances the binding of phospholipid vesi- 
cles containing DPPC to the plasma membrane derived 
from type II cells. This may contribute, in part, to the 
process of the SP-A-mediated lipid uptake by type II cells. 
We used density gradient centrifugation with several 
layers of sucrose. Since alkaline phosphatase is located on 
the plasma membrane of alveolar type II cells [24], we 
collected the pellet fraction as the plasma membrane in 
which most of alkaline phosphatase activity is localized. 
There raised a possibility that the liposomes aggregated by 
SP-A may be simply cosedimented with the pellet fraction. 
However, the control experiments without plasma mem- 
brane showed that the sedimentation profile shifted slightly 
to the right in the presence of SP-A, but that the liposomes 
cosedimented with the pellet fraction without plasma mem- 
brane was negligible when compared to the experiments 
with plasma membrane. Thus, the radioactive liposomes 
cosedimented with the pellet fraction is considered to be 
those associated with the plasma membrane. 
When the isolated plasma membrane was applied to the 
sucrose density gradient centrifugation after the incubation 
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with radiolabeled liposomes, approx. 66% of the mem- 
brane was recovered in the pellet fraction in the absence of 
SP-A; this was estimated by the distribution of the alkaline 
phosphatase activity (see Fig. 1C). Some of the plasma 
membranes were cosedimented with the gradients with 
lower densities. However, the addition of SP-A in the 
incubation mixture resulted in only 6% of increase in the 
alkaline phosphatase activity in the pellet fraction, indicat- 
ing that SP-A does not appear to increase the aggregation 
of the plasma membrane significantly when estimated by 
sucrose density gradients. On the other hand, SP-A in- 
creased the binding of liposomes to type II cell membranes 
more than 4-fold. Thus, there appears to be little possibil- 
ity that the enhanced association of liposomes with the 
type II cell membrane could be simply due to the SP-A- 
mediated aggregation of the plasma membrane and subse- 
quent rapping of the radiolabeled liposomes. 
Our previous tudy [16] has shown that the SP-A-medi- 
ated uptake of phosphatidylcholine by type II cells is 
preferential for DPPC and suggested that SP-A facilitates 
the incorporation of DPPC into lamellar bodies. Our pre- 
sent study is on this line. Lumb et al. [26] demonstrated 
that a protein derived from canine lung lavage, but not 
SP-A, catalyzed the transfer of phospholipids. This protein 
transferred saturated and unsaturated phosphatidylcholine 
and phosphatidylinositol but failed to transfer phospha- 
tidylglycerol. The present study confirmed their result of 
SP-A possessing no activity of lipid transfer. The phospho- 
lipid transfer protein may play a role in the recycling of 
phospholipid in concert with surfactant proteins. 
This study indicates that the SP-A-mediated association 
of phospholipid vesicles is preferential for those containing 
DPPC; this is approx. 2-fold higher than that of those 
containing PLPC. The aggregation activity of DPPC lipo- 
somes induced by SP-A appeared to be only by 15% 
higher than that of PLPC liposomes; the 2-fold difference 
in the membrane association between DPPC- and PLPC- 
containing liposomes does not appear to be explained only 
by the vesicle aggregation activity. In the absence of SP-A 
the percent of DPPC liposomes associated with type II cell 
plasma membrane is higher than that of PLPC liposomes. 
The uptake experiments by Wright et al. [15] with type II 
cells, alveolar macrophages and fibroblasts howed that in 
the absence of SP-A the amount of DPPC taken up by type 
II cells was increased approximately by two-fold greater 
than those by alveolar macrophages and fibroblasts. 
Suwabe et al. [27] reported that DPPC inhibited surfactant 
secretion by type II cells. This inhibition was cell-type 
specific. Unsaturated phosphatidylcholine such as PLPC 
failed to inhibit secretion. This suggests that DPPC may 
selectively fuse with the plasma membrane of type II cells. 
The present result that DPPC liposomes preferentially 
associate with type II cell plasma membrane in the absence 
of SP-A may support his assumption. 
We also found that the plasma membrane derived from 
alveolar type II cells possessed higher activity as a accep- 
tor for the binding of DPPC liposomes than that derived 
from liver in the presence of SP-A. The phospholipid to 
protein ratio of the plasma membranes i olated from type 
II cells and liver were 0.775 +0.083 nmol phospho- 
lipid//xg protein (mean + S.D., n = 3) and 0.630 _ 0.014 
nmol//zg, respectively. Although the content of phospho- 
lipids in type II cell membrane appears to be slightly 
higher than that in liver membrane, the amount of radiola- 
beled liposomes associated with type II cell membranes 
was more than 2-fold greater than those associated with 
liver membrane. Thus, it is unlikely that the 2-fold differ- 
ence in liposome binding between the membranes from 
type II cells and liver may be caused by approx. 20% 
difference of the phospholipid contents between these 
membranes. Alveolar type II cells express a high-affinity 
receptor for SP-A [5,6]. Chemical modification studies 
demonstrate hat cell surface binding activity of SP-A is 
directly related to its capacity to inhibit surfactant lipid 
secretion by type II cells [28]. Additional studies are 
needed to clarify whether lipid uptake by type II cells and 
the lipid association with type II cell plasma membrane 
utilize the same receptor that regulates surfactant secretion, 
although the membrane topology may differ from that of 
intact cells after the plasma membrane is isolated. SP-A 
also increased the amount of liposomes associated with 
liver plasma membrane, albeit to a lesser extent, as well as 
type II cell plasma membrane. In the study described by 
Wright et al. [15], SP-A at 15 /.~g/ml also increased the 
association of DPPC with two lines of fibroblasts, albeit 
total amounts increased by SP-A is clearly lower than 
those with type II cells. The mechanism by which SP-A 
increases the association of liposomes with the mem- 
branes, which are not derived from type II cells, is unclear. 
In conclusion, SP-A increased the binding of liposomes 
containing DPPC to the plasma membrane isolated from 
type II cells. The SP-A-mediated association of liposomes 
containing DPPC with type II cell plasma membrane was 
greater than liposomes containing PLPC or the plasma 
membrane derived from liver. 
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